Ranked #1 in Bengaluru by Outlook - Best Oncology Hospital
Know More
Areas of Special Interest:
– Solid and hematological malignancies.
– Chemotherapy, targeted therapy &
immunotherapy.
– Onco-hematology and bone marrow
disorders.
– Clinical research & oncology trials.
– Patient-centric cancer care.
– Bone Marrow Transplantation/Stem Cell
Transplantation.
Key Achievements:
– Part of Editorial Board Cancer Science
and Research Journal.
Awards and Recognition:
– Best paper award at European Society of
Oncology in 2012.
– Best paper award for Hereditary cancer
category in 2014.
Membership:
– American Society of Medical Oncology.
– European Society of Medical Oncology
Publications:
– Neurofibromatosis type I with
breast cancer:not only for women!
Published in hereditary cancer in
clinical practice journal.
– FIP1L1-PDGFRA positive chronic
eosinophilic leukemia – low burden
disease with dramatic response to
imatinib original article published
in turkish journal of hematology
journal.
Areas of Special Interest:
– Solid and hematological malignancies.
– Chemotherapy, targeted therapy &
immunotherapy.
– Onco-hematology and bone marrow
disorders.
– Clinical research & oncology trials.
– Patient-centric cancer care.
– Bone Marrow Transplantation/Stem Cell
Transplantation.
Key Achievements:
– Part of Editorial Board Cancer Science
and Research Journal.
Awards and Recognition:
– Best paper award at European Society of
Oncology in 2012.
– Best paper award for Hereditary cancer
category in 2014.
Membership:
– American Society of Medical Oncology.
– European Society of Medical Oncology
Publications:
– Neurofibromatosis type I with
breast cancer:not only for women!
Published in hereditary cancer in
clinical practice journal.
– FIP1L1-PDGFRA positive chronic
eosinophilic leukemia – low burden
disease with dramatic response to
imatinib original article published
in turkish journal of hematology
journal.
